Leora Herrmann
Leora Herrmann was diagnosed with Chronic Lymphocytic Leukemia in 2012. She experienced several years of debilitating fatigue and brain fog that were finally alleviated in 2017 after she completed a clinical trial of triplet therapy with Obinituzumab, Venetoclax and Ibrutinib. For this, she will be forever grateful. Leora has served as the Maryland Advocacy Chair for the Leukemia & Lymphoma Society and is currently on the Steering Committee of the Transplant Recipient and Immunocompromised Advocacy Group (TRAIPAG). Prior to her diagnosis, Leora was an intellectual property litigator. She lives in Baltimore, MD (USA) with her Border Collie, Nik.
Blood cancer patients who are still having difficulty getting Evusheld can download the FDA's revised Evusheld Fact Sheet for Health Providers and sen…
The Leukemia & Lymphoma Society (LLS) has published the results of its Patient Registry study measuring (i) T cell responses to the Covid mRNA vac…